Review



gls1  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc gls1
    Gls1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/pm41708583-113-3-13
    Average 86 stars, based on 1 article reviews
    gls1 - by Bioz Stars, 2026-11
    86/100 stars

    Images

    Related Articles

    Cell-Signaling:

    Article Title: Taurine is a natural suppressor of urea cycle via targeting ASL.
    Article Snippet: Antibodies that recognize TUBULIN (11224-1-AP) and ASL (16645-1-AP) were purchased from Proteintech. .. Antibodies that recognize GLS1 (56750), FOS (2250S) and c-Jun (9165S) were purchased from Cell Signaling Technology. .. Antibody that recognizes PTER (PA520750) was purchased from Thermo Fisher.



    Similar Products

    96
    MedChemExpress gls1 cb839
    Gls1 Cb839, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/Telaglenastat/pm42984143-88-8-13
    Average 96 stars, based on 1 article reviews
    gls1 cb839 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    95
    MedChemExpress bptes gls1 inhibitor medchemexpress hy
    Bptes Gls1 Inhibitor Medchemexpress Hy, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/BPTES/pm41947198-748-7-10
    Average 95 stars, based on 1 article reviews
    bptes gls1 inhibitor medchemexpress hy - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    96
    MedChemExpress cb 839 gls1 inhibitor medchemexpress hy
    Cb 839 Gls1 Inhibitor Medchemexpress Hy, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/Telaglenastat/pm41947198-748-0-3
    Average 96 stars, based on 1 article reviews
    cb 839 gls1 inhibitor medchemexpress hy - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Proteintech gls1
    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and <t>GLS1</t> in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Gls1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/KGA%2FGAC+Antibody/pmc12948417-238-40-41
    Average 94 stars, based on 1 article reviews
    gls1 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Jackson Laboratory gls1 mice
    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and <t>GLS1</t> in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Gls1 Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/fl+fl+mice+trp53/pmc12948417-199-1-17
    Average 86 stars, based on 1 article reviews
    gls1 mice - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc gls1
    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and <t>GLS1</t> in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Gls1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/pm41708583-113-3-13
    Average 86 stars, based on 1 article reviews
    gls1 - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc gls human
    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and <t>GLS1</t> in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Gls Human, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/Glutaminase-1%2FGLS1+Rabbit+mAb/pm41639460-653-61-62
    Average 94 stars, based on 1 article reviews
    gls human - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc rabbit antigls1
    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and <t>GLS1</t> in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Rabbit Antigls1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/Glutaminase-1%2FGLS1+XP+Rabbit+mAb/pm41650851-82-6-10
    Average 94 stars, based on 1 article reviews
    rabbit antigls1 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and GLS1 in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: The Journal of Clinical Investigation

    Article Title: α -Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models

    doi: 10.1172/JCI172380

    Figure Lengend Snippet: ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and GLS1 in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: The membranes were incubated overnight at 4°C with primary antibodies against SOX9 (Abcam, ab3697; 1:1,000); Collagen II (Abcam, ab85266; 1:1,000); MMP3 (Abcam, ab52915; 1:1,000); MMP13 (Proteintech, 18165-1-AP; 1:1,000); ADAMTS5 (Abcam, ab41037; 1:200); NOS2 (Abcam, ab178945; 1:1,000); SLC1A5 (Sigma, HPA035239; 1:1,000); GLS1 (Proteintech; 12855-1-ap; 1:1,000); GS (Abcam, ab176562; 1:1,000); NF-κB p65 (Santa Cruz Biotechnology; sc-8008; 1:1,000); lamin A/C (Santa Cruz Biotechnology; sc-6215; 1:5,000); phospho-IKKα/β (Cell Signaling Technology; 2694P; 1:1,000); IKKα/β (Abcam, ab178870; 1:1,000); phospho-IκBα (Affinity, AF2002; 1:1,000); IκBα (Affinity, AF5002; 1:1,000); TRAF6 (Santa Cruz Biotechnology; sc-8409; 1:200); K63 Ub (Cell Signaling Technology; 5621S; 1:1,000); and GAPDH (Abcam, ab8245; 1:2,000).

    Techniques: Liquid Chromatography with Mass Spectroscopy, Control, Quantitative RT-PCR, Western Blot, Immunofluorescence, Staining

    ( A and B ) mRNA ( A ) and Western blot ( B ) analysis of the indicated anabolic and catabolic factors in chondrocytes treated with BPTES or IL-1β alone or with combined BPTES and IL-1β for 24 hours. The culture medium contained 4 mM Gln. Blots are representative of 3 independent experiments. Ctrl, control. ( C ) Representative safranin O/fast green staining images and OARSI scores ( n = 8 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( D ) Representative MMP13 and NOS2 IHC staining images and quantification of cells positive for MMP13 and NOS2 ( n = 5 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( E ) Safranin O/fast green staining and OARSI scores in joint sections of mice at 8 weeks after DMM surgery. Ad-Ctrl or Ad- Gls1 was intra-articularly injected once per week for 3 weeks beginning at 10 days after surgery ( n = 8 mice per group). Scale bars: 20 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: The Journal of Clinical Investigation

    Article Title: α -Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models

    doi: 10.1172/JCI172380

    Figure Lengend Snippet: ( A and B ) mRNA ( A ) and Western blot ( B ) analysis of the indicated anabolic and catabolic factors in chondrocytes treated with BPTES or IL-1β alone or with combined BPTES and IL-1β for 24 hours. The culture medium contained 4 mM Gln. Blots are representative of 3 independent experiments. Ctrl, control. ( C ) Representative safranin O/fast green staining images and OARSI scores ( n = 8 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( D ) Representative MMP13 and NOS2 IHC staining images and quantification of cells positive for MMP13 and NOS2 ( n = 5 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( E ) Safranin O/fast green staining and OARSI scores in joint sections of mice at 8 weeks after DMM surgery. Ad-Ctrl or Ad- Gls1 was intra-articularly injected once per week for 3 weeks beginning at 10 days after surgery ( n = 8 mice per group). Scale bars: 20 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: The membranes were incubated overnight at 4°C with primary antibodies against SOX9 (Abcam, ab3697; 1:1,000); Collagen II (Abcam, ab85266; 1:1,000); MMP3 (Abcam, ab52915; 1:1,000); MMP13 (Proteintech, 18165-1-AP; 1:1,000); ADAMTS5 (Abcam, ab41037; 1:200); NOS2 (Abcam, ab178945; 1:1,000); SLC1A5 (Sigma, HPA035239; 1:1,000); GLS1 (Proteintech; 12855-1-ap; 1:1,000); GS (Abcam, ab176562; 1:1,000); NF-κB p65 (Santa Cruz Biotechnology; sc-8008; 1:1,000); lamin A/C (Santa Cruz Biotechnology; sc-6215; 1:5,000); phospho-IKKα/β (Cell Signaling Technology; 2694P; 1:1,000); IKKα/β (Abcam, ab178870; 1:1,000); phospho-IκBα (Affinity, AF2002; 1:1,000); IκBα (Affinity, AF5002; 1:1,000); TRAF6 (Santa Cruz Biotechnology; sc-8409; 1:200); K63 Ub (Cell Signaling Technology; 5621S; 1:1,000); and GAPDH (Abcam, ab8245; 1:2,000).

    Techniques: Western Blot, Control, Staining, Immunohistochemistry, Injection

    ( A ) IB analysis of K63-linked ubiquitination of TRAF6 in HEK293T cells transfected to express HA-TRAF6 with or without Flag-tagged K63-linked ubiquitin (Flag-K63-Ub) and MYC-tagged UBE2O (MYC-UBE2O). ( B ) Densitometry of the bands in A , showing the ubiquitination (Ub) of TRAF6, presented relative to results obtained with cells transfected to express empty vector, set as 100%. ( C ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 in IL-1β–stimulated chondrocytes in the presence of BPTES. Blots are representative of 3 independent experiments. ( D ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 that was immunoprecipitated and TRAF6 from IL-1β– and DM-αKG–stimulated chondrocytes. ( E ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 immunoprecipitated from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( F ) Protein quantitative analysis of the nuclear p65 from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG for 60 minutes. ( G and H ) Quantitative analysis of qRT-PCR ( G ) and Western blot ( H ) analysis for the indicated anabolic and catabolic factors from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( I ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells at 25 weeks in mice fed a standard diet (SD) or HFD. ( J ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells in Gls1 −/− mice and their Gls1 fl/fl control littermates after DMM surgery. veh, vehicle. ( K ) Schematic depicting the described findings: αKG inhibited the TRAF6 ubiquitination via inducing the expression of UBE2O in OA chondrocytes. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: The Journal of Clinical Investigation

    Article Title: α -Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models

    doi: 10.1172/JCI172380

    Figure Lengend Snippet: ( A ) IB analysis of K63-linked ubiquitination of TRAF6 in HEK293T cells transfected to express HA-TRAF6 with or without Flag-tagged K63-linked ubiquitin (Flag-K63-Ub) and MYC-tagged UBE2O (MYC-UBE2O). ( B ) Densitometry of the bands in A , showing the ubiquitination (Ub) of TRAF6, presented relative to results obtained with cells transfected to express empty vector, set as 100%. ( C ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 in IL-1β–stimulated chondrocytes in the presence of BPTES. Blots are representative of 3 independent experiments. ( D ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 that was immunoprecipitated and TRAF6 from IL-1β– and DM-αKG–stimulated chondrocytes. ( E ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 immunoprecipitated from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( F ) Protein quantitative analysis of the nuclear p65 from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG for 60 minutes. ( G and H ) Quantitative analysis of qRT-PCR ( G ) and Western blot ( H ) analysis for the indicated anabolic and catabolic factors from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( I ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells at 25 weeks in mice fed a standard diet (SD) or HFD. ( J ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells in Gls1 −/− mice and their Gls1 fl/fl control littermates after DMM surgery. veh, vehicle. ( K ) Schematic depicting the described findings: αKG inhibited the TRAF6 ubiquitination via inducing the expression of UBE2O in OA chondrocytes. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: The membranes were incubated overnight at 4°C with primary antibodies against SOX9 (Abcam, ab3697; 1:1,000); Collagen II (Abcam, ab85266; 1:1,000); MMP3 (Abcam, ab52915; 1:1,000); MMP13 (Proteintech, 18165-1-AP; 1:1,000); ADAMTS5 (Abcam, ab41037; 1:200); NOS2 (Abcam, ab178945; 1:1,000); SLC1A5 (Sigma, HPA035239; 1:1,000); GLS1 (Proteintech; 12855-1-ap; 1:1,000); GS (Abcam, ab176562; 1:1,000); NF-κB p65 (Santa Cruz Biotechnology; sc-8008; 1:1,000); lamin A/C (Santa Cruz Biotechnology; sc-6215; 1:5,000); phospho-IKKα/β (Cell Signaling Technology; 2694P; 1:1,000); IKKα/β (Abcam, ab178870; 1:1,000); phospho-IκBα (Affinity, AF2002; 1:1,000); IκBα (Affinity, AF5002; 1:1,000); TRAF6 (Santa Cruz Biotechnology; sc-8409; 1:200); K63 Ub (Cell Signaling Technology; 5621S; 1:1,000); and GAPDH (Abcam, ab8245; 1:2,000).

    Techniques: Ubiquitin Proteomics, Transfection, Plasmid Preparation, Western Blot, Immunoprecipitation, Quantitative RT-PCR, Immunohistochemistry, Control, Expressing

    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and GLS1 in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: The Journal of Clinical Investigation

    Article Title: α -Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models

    doi: 10.1172/JCI172380

    Figure Lengend Snippet: ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and GLS1 in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: Floxed Gls1 mice ( ) (catalog 017894) and Col2a1-CreERT2 mice ( ) (catalog 006774) were purchased from The Jackson Laboratory.

    Techniques: Liquid Chromatography with Mass Spectroscopy, Control, Quantitative RT-PCR, Western Blot, Immunofluorescence, Staining

    ( A and B ) mRNA ( A ) and Western blot ( B ) analysis of the indicated anabolic and catabolic factors in chondrocytes treated with BPTES or IL-1β alone or with combined BPTES and IL-1β for 24 hours. The culture medium contained 4 mM Gln. Blots are representative of 3 independent experiments. Ctrl, control. ( C ) Representative safranin O/fast green staining images and OARSI scores ( n = 8 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( D ) Representative MMP13 and NOS2 IHC staining images and quantification of cells positive for MMP13 and NOS2 ( n = 5 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( E ) Safranin O/fast green staining and OARSI scores in joint sections of mice at 8 weeks after DMM surgery. Ad-Ctrl or Ad- Gls1 was intra-articularly injected once per week for 3 weeks beginning at 10 days after surgery ( n = 8 mice per group). Scale bars: 20 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: The Journal of Clinical Investigation

    Article Title: α -Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models

    doi: 10.1172/JCI172380

    Figure Lengend Snippet: ( A and B ) mRNA ( A ) and Western blot ( B ) analysis of the indicated anabolic and catabolic factors in chondrocytes treated with BPTES or IL-1β alone or with combined BPTES and IL-1β for 24 hours. The culture medium contained 4 mM Gln. Blots are representative of 3 independent experiments. Ctrl, control. ( C ) Representative safranin O/fast green staining images and OARSI scores ( n = 8 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( D ) Representative MMP13 and NOS2 IHC staining images and quantification of cells positive for MMP13 and NOS2 ( n = 5 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( E ) Safranin O/fast green staining and OARSI scores in joint sections of mice at 8 weeks after DMM surgery. Ad-Ctrl or Ad- Gls1 was intra-articularly injected once per week for 3 weeks beginning at 10 days after surgery ( n = 8 mice per group). Scale bars: 20 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: Floxed Gls1 mice ( ) (catalog 017894) and Col2a1-CreERT2 mice ( ) (catalog 006774) were purchased from The Jackson Laboratory.

    Techniques: Western Blot, Control, Staining, Immunohistochemistry, Injection

    ( A ) IB analysis of K63-linked ubiquitination of TRAF6 in HEK293T cells transfected to express HA-TRAF6 with or without Flag-tagged K63-linked ubiquitin (Flag-K63-Ub) and MYC-tagged UBE2O (MYC-UBE2O). ( B ) Densitometry of the bands in A , showing the ubiquitination (Ub) of TRAF6, presented relative to results obtained with cells transfected to express empty vector, set as 100%. ( C ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 in IL-1β–stimulated chondrocytes in the presence of BPTES. Blots are representative of 3 independent experiments. ( D ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 that was immunoprecipitated and TRAF6 from IL-1β– and DM-αKG–stimulated chondrocytes. ( E ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 immunoprecipitated from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( F ) Protein quantitative analysis of the nuclear p65 from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG for 60 minutes. ( G and H ) Quantitative analysis of qRT-PCR ( G ) and Western blot ( H ) analysis for the indicated anabolic and catabolic factors from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( I ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells at 25 weeks in mice fed a standard diet (SD) or HFD. ( J ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells in Gls1 −/− mice and their Gls1 fl/fl control littermates after DMM surgery. veh, vehicle. ( K ) Schematic depicting the described findings: αKG inhibited the TRAF6 ubiquitination via inducing the expression of UBE2O in OA chondrocytes. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: The Journal of Clinical Investigation

    Article Title: α -Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models

    doi: 10.1172/JCI172380

    Figure Lengend Snippet: ( A ) IB analysis of K63-linked ubiquitination of TRAF6 in HEK293T cells transfected to express HA-TRAF6 with or without Flag-tagged K63-linked ubiquitin (Flag-K63-Ub) and MYC-tagged UBE2O (MYC-UBE2O). ( B ) Densitometry of the bands in A , showing the ubiquitination (Ub) of TRAF6, presented relative to results obtained with cells transfected to express empty vector, set as 100%. ( C ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 in IL-1β–stimulated chondrocytes in the presence of BPTES. Blots are representative of 3 independent experiments. ( D ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 that was immunoprecipitated and TRAF6 from IL-1β– and DM-αKG–stimulated chondrocytes. ( E ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 immunoprecipitated from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( F ) Protein quantitative analysis of the nuclear p65 from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG for 60 minutes. ( G and H ) Quantitative analysis of qRT-PCR ( G ) and Western blot ( H ) analysis for the indicated anabolic and catabolic factors from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( I ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells at 25 weeks in mice fed a standard diet (SD) or HFD. ( J ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells in Gls1 −/− mice and their Gls1 fl/fl control littermates after DMM surgery. veh, vehicle. ( K ) Schematic depicting the described findings: αKG inhibited the TRAF6 ubiquitination via inducing the expression of UBE2O in OA chondrocytes. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: Floxed Gls1 mice ( ) (catalog 017894) and Col2a1-CreERT2 mice ( ) (catalog 006774) were purchased from The Jackson Laboratory.

    Techniques: Ubiquitin Proteomics, Transfection, Plasmid Preparation, Western Blot, Immunoprecipitation, Quantitative RT-PCR, Immunohistochemistry, Control, Expressing